Data / Form D filings / SUPERNUS PHARMACEUTICALS INC
SUPERNUS PHARMACEUTICALS INC: Form D filings
SUPERNUS PHARMACEUTICALS INC, a pharmaceuticals company in Rockville, MD, filed 2 Form D notices with the SEC between 2011 and 2012. The latest, on February 16, 2012, reports $30 million sold of a $30 million offering to 3 investors.
Find out what SUPERNUS PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1550 E GUDE DR, Rockville, MD, 20850
- Phone
- (301) 838-2500
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1356576
The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 16, 2012 | Amendment | $30,000,000 | $30,000,000 | $0 | 3 | Jan 26, 2011 | sec.gov |
| Feb 2, 2011 | New notice | $25,000,000 | $15,000,000 | $10,000,000 | 2 | Jan 26, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John M. Siebert | Director | |
| Michael James Bigham | Director | |
| William A. Nuerge | Director | |
| Michael B. Sheffery, Ph.D. | Director | |
| Padmanabh P. Bhatt, Ph.D. | Executive Officer | |
| Charles W. Newhall, III | Director | |
| M. James Barrett, Ph.D. | Director | |
| Paolo P. Baroldi, M.D., Ph.D. | Executive Officer | |
| Frederick M. Hudson | Director | |
| Jack A. Khattar | Executive Officer, Director | |
| Tami T. Martin, R.N., Esq. | Executive Officer | |
| Russell P. Wilson | Executive Officer | |
| Jones W. Bryan, Ph.D. | Executive Officer |
Every Form D from the week of Feb 13, 2012 · All recent filings in Maryland · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what SUPERNUS PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.